We have known that CD4+ and CD8+ T cells are present at the epidermal and dermal junctions near vitiligo lesions, and CD8+ T cells have been proven to induce melanocytes loss, underscoring the role of T cell-mediated immunity in the pathogenesis of vitiligo (84). The gene discussed is CD8A; the disease is vitiligo.